Manganese in Women With Encephalopathy
Manganese in Women With Encephalopathy
Objective:

 Report manganese serum levels and mortality in encephalopathic patients.

 Patients and participants:

 Consecutive patients aged > 18 years, with hepatic encephalopathy and informed consent signed
 by their families.

 Interventions:

 Patients' clinical characteristics as well as biochemical tests of renal function,
 hemoglobin, glucose and albumin levels were obtained as well as a blood sample to analyze
 manganese levels with a graphite furnace atomic absorption spectrometer.

 Hypothesis:

 There is a difference in the manganese levels between male and female patients.
Inclusion Criteria:

 -  Consecutive patients aged > 18 years

 -  With hepatic encephalopathy

 -  Informed consent signed by their families

 Exclusion Criteria:

 -  Portal bypass surgery

 -  Cancer of any localization

 -  Known malignancy and other severe diseases which shorten life expectancy < 6 months

 -  Psychiatric illness